Specific strains of Christensen bacteria can selectively enhance the anti-cancer effect of off-target low-dose intestinal irradiation and PD-L1 blockade, and promote the migration of intestinal dendritic cells expressing PD-L1 to tumor-draining lymph nodes. This evidence concerns the gene CD274 and neoplasm.